Pharmaceutical Raw Materials Sex Enhancement Series Avanafil for Muscle Gain 330784-47-9

Pharmaceutical Raw Materials Sex Enhancement Series Avanafil for Muscle Gain 330784-47-9

Abstrakt

FALL:330784-47-9
MF:C23H26ClN7O3
MW:483.95
Schmelzpunkt:150-152° C.
Dichte 1.372
Lagertemperatur. Kühlschrank
Verwendung: Used for the treatment of erectile dysfunction. A phosphodiesterase 5 Inhibitor.
Store: Store at room temperature away from moisture, Hitze, and light

Beschreibung:

Avanafil is a PDE5 inhibitor approved for erectile dysfunction by FDA on April 27, 2012 and by EMA on June 21, 2013. Avanafil is known by the trademark names and Spedra and was developed by Vivus Inc. Avanafil wirkt, indem es einen bestimmten Phosphodiesterase-Typ hemmt 5 Enzym, das in verschiedenen Körpergeweben vorkommt, aber hauptsächlich im Corpus Cavernosum Penis, sowie die Netzhaut. Andere ähnliche Medikamente sind Tadalafil und Vardenafil. Der Vorteil von Avanafil besteht darin, dass die Wirkung im Vergleich zu anderen PDE5-Hemmern sehr schnell einsetzt. Es zieht schnell ein, Erreichen einer maximalen Konzentration in etwa 30-45 Protokoll. About two-thirds of the participants were able to engage in sexual activity within 15 minutes..

Anwendungen:

Avanafil is used to treat erectile dysfunction (ED: impotence; inability to get or keep an erection in men). Avanafil is in a class of medications called phosphodiesterase (PDE) Inhibitoren. It works by increasing blood flow to the penis during sexual stimulation. This increased blood flow can cause an erection. Avanafil does not cure erectile dysfunction or increase sexual desire. Avanafil does not prevent pregnancy or the spread of sexually transmitted diseases such as human immunodeficiency virus (HIV).

Echtheitszertifikat :